Based on the results of Esteves et al., the authors hypothesized that increased UCP2 expression in melanoma cells limits the aerobic glycolysis of tumor cells, allowing glucose to be available for consumption by lymphocytes [111,117]. Here, UCP2 is linked to melanoma.